Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

2,357 recalls · Class II, newest first

Class II · Moderate risk

Lacosamide Oral Solution

Defective Container: This recall is being initiated due to a leaking unit stored horizontally.

Ongoing Packaging defect Apotex Corp. NDC 60505-0405-4 D-0457-2025
Class II · Moderate risk

Cephalexin for Oral Suspension

Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity was identified to be Cephalexin Glucose Adduct.

Ongoing Impurity / degradation Ascend Laboratories, LLC NDC 67877-544-68 D-0469-2025
Class II · Moderate risk

Cephalexin for Oral Suspension

Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity was identified to be Cephalexin Glucose Adduct.

Ongoing Impurity / degradation Ascend Laboratories, LLC NDC 67877-544-88 D-0468-2025
Class II · Moderate risk

Acetaminophen Tablets

cGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets).

Ongoing Failed specification Aurobindo Pharma USA Inc NDC 72288-405-10 D-0471-2025
Class II · Moderate risk

Semaglutide

Lack of Assurance of Sterility

Ongoing Sterility / contamination Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) D-0480-2025
Class II · Moderate risk

Semaglutide

Lack of Assurance of Sterility

Ongoing Sterility / contamination Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) D-0479-2025
Class II · Moderate risk

LX Bioboost Plus

Lack of Assurance of Sterility

Ongoing Sterility / contamination Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado) D-0477-2025
Class II · Moderate risk

Theophylline

OOS results reported for the Dissolution (by UV) test.

Ongoing Dissolution failure Glenmark Pharmaceuticals Inc., USA D-0452-2025
Class II · Moderate risk

BD ChloraPrep Clear

Lack of Assurance of Sterility: The affected product may exhibit an open seal on the packaging of the applicator.

Ongoing Sterility / contamination CareFusion 213, LLC NDC 54365-400-31 D-0441-2025

Recalls by year